Skip to content

13F-HR filed by HealthCor Management, L.P.

HealthCor Management, L.P. filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 54 holding rows worth $2,593,092,000.

Accession
0001343781-21-000002
Filed
2021-02-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A holdings report, 54 entries on the cover page, a total value of $2,593,092,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,593,092,000 with VALUE read as thousands by filing date, 13F file number 028-11790. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HORIZON THERAPEUTICS PLCG46188101SHS2,118,090$154,938,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock803,310$143,929,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM583,290$137,855,000thousands by filing date
THE COOPER COMPANIES216648402COM NEW345,630$125,574,000thousands by filing date
HCA Healthcare Inc40412C101COM711,240$116,971,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock902,601$100,342,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock6,937,448$95,945,000thousands by filing date
AbbVie,Inc.00287Y109COM853,650$91,469,000thousands by filing date
HUMANA INC COM444859102Stock220,181$90,334,000thousands by filing date
MARAVAI LIFESCIENCES HLDGS A56600D107COMMON STOCK3,134,712$87,929,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock551,384$84,963,000thousands by filing date
BIO RAD LABS INC090572207CL A140,080$81,658,000thousands by filing date
Bristol-Myers Squibb Company110122108COM1,297,700$80,496,000thousands by filing date
HOLOGIC INC436440101COM1,017,280$74,089,000thousands by filing date
MCKESSON CORP COM58155Q103Stock422,800$73,533,000thousands by filing date
Medtronic PlcG5960L103COM604,150$70,770,000thousands by filing date
GUARDANT HEALTH INC COM40131M109Stock543,160$70,002,000thousands by filing date
Johnson & Johnson478160104COM435,010$68,462,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock566,370$67,256,000thousands by filing date
ROYALTY PHARMA PLCG7709Q104SHS CLASS A1,339,530$67,043,000thousands by filing date
UnitedHealth Group Inc91324P102COM174,990$61,365,000thousands by filing date
SYNEOS HEALTH INC87166B102CL A793,320$54,049,000thousands by filing date
INVESCO QQQ TR46090E103COM140,000$43,924,000thousands by filing dateput
AGIOS PHARMACEUTICALS INC00847X104COM997,070$43,203,000thousands by filing date
LIVANOVA PLCG5509L101SHS616,030$40,787,000thousands by filing date
ENVISTA HOLDINGS CORPORATION29415F104COM1,039,290$35,055,000thousands by filing date
VENTAS INC COM92276F100REIT658,350$32,285,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock321,200$29,303,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS400,000$29,260,000thousands by filing datecall
CATALENT INC USD 0.01148806102COM270,250$28,125,000thousands by filing date
SPY78462F103SHS75,000$28,041,000thousands by filing dateput
OMEGA HEALTHCARE INVS INC COM681936100REIT770,910$27,999,000thousands by filing date
NEVRO CORP64157F103COM156,046$27,012,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM107,800$26,935,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM1,070,550$23,809,000thousands by filing date
WELLTOWER INC COM95040Q104REIT357,120$23,077,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM226,460$21,706,000thousands by filing date
iShares Russell 2000 ETF464287655SHS105,000$20,586,000thousands by filing dateput
BIOMARIN PHARMACEUTICAL INC09061G101COM222,210$19,486,000thousands by filing date
CURIS INC231269200COM2,374,370$19,446,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock431,441$17,227,000thousands by filing date
CONMED CORP COM207410101Stock100,000$11,200,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM61,330$9,582,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM139,210$7,945,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM250,000$5,773,000thousands by filing dateput
TELEFLEX INCORPORATED879369106COM13,150$5,412,000thousands by filing date
CERTARA INC COM15687V109Stock150,000$5,058,000thousands by filing date
BIOGEN INC COM09062X103Stock9,560$2,341,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW392,760$1,921,000thousands by filing date
Cigna Corporation125523100COM8,502$1,770,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK55,150$1,754,000thousands by filing date
INCYTE CORP COM45337C102Stock19,530$1,699,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock86,930$1,479,000thousands by filing date
ANIKA THERAPEUTICS INC035255108COM20,320$920,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001343781-21-000002this filing2021-02-16acceptance time not in the bulk data set